Katharine Yao to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Katharine Yao has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
1.245
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
Score: 0.343
-
Regional Variation in Performance for Commission on Cancer Breast Quality Measures and Impact on Overall Survival. Ann Surg Oncol. 2018 Oct; 25(10):3069-3075.
Score: 0.319
-
The Impact of Facility Volume on Rates of Pathologic Complete Response to Neoadjuvant Chemotherapy Used in Breast Cancer. Ann Surg Oncol. 2017 Oct; 24(11):3157-3166.
Score: 0.298
-
Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015 Mar; 22(3):899-907.
Score: 0.245
-
Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res. 2008 Jul 01; 68(13):5226-35.
Score: 0.040